Comparison of 1H MR spectroscopy, 3-point DIXON, and multi-echo gradient echo for measuring hepatic fat fraction

Magnetic Resonance in Medical Sciences

Volumn 10, Issue 1, 2011, Pages 41-48

  Ishizaka, Kinya ^a   Oyama, Noriko ^a   Mito, Suzuko ^a   Sugimori, Hiroyuki ^a   Nakanishi, Mitsuhiro ^a   Okuaki, Tomoyuki ^b   Shirato, Hiroki ^a   Terae, Satoshi ^a  

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^b Medical Satellite Yaesu Clinic   (Japan)

Author keywords

1H MRS; DIXON; Hepatic fat fraction; Multi echo gradient echo

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; FATTY LIVER; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REGRESSION ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; FATTY LIVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 79960938537     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.10.41     Document Type: Article

References (23)

1. Sanyal AJ. American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123:1705-1725.
2. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34:255-262.
3. Brunt EM, Janney CG, Di Bisceglie AM, Neu-schwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
4. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-1321.
5. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gas-troenterol 1999; 5:301-304.
6. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128:1898-1906.
7. Qayyum A, Chen DM, Breiman RS, et al. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 2009; 33:110-115.
8. Zhong L, Chen JJ, Chen J, et al. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. J Dig Dis 2009; 10:315-320.
9. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51:433-445.
10. Mennesson N, Dumortier J, Hervieu V, et al. Liver steatosis quantîcation using magnetic resonance imaging: a prospective comparative study with liver biopsy. J Comput Assist Tomogr 2009; 33: 672-677.
11. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse paren-chymal liver disease. Clin Radiol 1991; 43:26-31.
12. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123:745-750.
13. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15:539-543.
14. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5T. Radiology 2009; 251:67-76.
15. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288:E462-E468.
16. Kim H, Taksali SE, Dufour S, et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med 2008; 59:521-527.
17. Yu H, McKenzie CA, Shimakawa A, et al. Mul-tiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007; 26:1153-1161.
18. Arai N, Miyati T, Matsunaga S, et al. [New method of determining regional fat fraction with modulus and real multiple gradient-echo (MRM-GRE)]. Nippon Hoshasen Gijutsu Gakkai Zasshi 2007; 63:312-318. [Article in Japanese]
19. Parizel PM, Van Riet B, van Hasselt BA, et al. In-fluence of magnetic field strength on T2* decay and phase effects in gradient echo MRI of vertebral bone marrow. J Comput Assist Tomogr 1995; 19: 465-471.
20. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Res-on Imaging 1995; 5:281-285.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
22. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007; 58:354-364.
23. De Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0T: preliminary results. Radiology 2004; 230:652-659.